Background Generally. an induction agent is chosen based on the conditions of the deceased donor and the recipient. Antithymocyte globulin (ATG) is preferred in relatively high-risk conditions. No clear evidence indicates which induction agent is safer or more efficient for deceased donor kidney transplantation (DDKT). https://fitnessgravesyardes.shop/product-category/audio-receiver/
The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
Internet 3 hours ago livozj48sry0Web Directory Categories
Web Directory Search
New Site Listings